The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
The role of tumor microenvironment in therapeutic resistance
Open accessAbstract
// Beomseok Son 1,* , Sungmin Lee 1,* , HyeSook Youn 2,* , EunGi Kim 1 , Wanyeon Kim 3,4 and BuHyun Youn 1,4 1 Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea 2 Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Republic of Korea 3 Integrative Graduate Program of Ship and Offshore Plant Technology for Ocean Energy Resource, Pusan National University, Busan 46241, Republic of Korea 4 Department of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea * These authors have contributed equally to this work Correspondence to: BuHyun Youn, email: // Wanyeon Kim, email: // Keywords : tumor microenvironment, therapeutic resistance, myeloid cells, cancer-associated fibroblasts, mesenchymal stem cells Received : September 02, 2016 Accepted : December 01, 2016 Published : December 11, 2016 Abstract Cancer cells undergo unlimited progression and survival owing to activation of oncogenes. However, support of the tumor microenvironment is essential to the formation of clinically relevant tumors. Recent evidence indicates that the tumor microenvironment is a critical regulator of immune escape, progression, and distant metastasis of cancer. Moreover, the tumor microenvironment is known to be involved in acquired resistance of tumors to various therapies. Despite significant advances in chemotherapy and radiotherapy, occurrence of therapeutic resistance leads to reduced efficacy. This review highlights myeloid cells, cancer-associated fibroblasts, and mesenchymal stem cells consisting of the tumor microenvironment, as well as the relevant signaling pathways that eventually render cancer cells to be therapeutically resistant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kaur, A., Webster, M. R., Marchbank, K., Behera, R., Ndoye, A., Kugel, C. H., Dang, V. M., Appleton, J., O’Connell, M. P., Cheng, P., et al. (2016) · Nature · doi:10.1038/nature17392 · Cited by 398
RetractedPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W.-J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305133 · Cited by 3,392
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Peng, W., Chen, J. Q., Liu, C., Malu, S., Creasy, C., Tetzlaff, M. T., Xu, C., McKenzie, J. A., Zhang, C., Liang, X., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0283 · Cited by 1,539
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Knowles, M. A., & Hurst, C. D. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3817 · Cited by 1,247
Tumour heterogeneity in the clinic
Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,211
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.07.004 · Cited by 1,044
Microvesicles: mediators of extracellular communication during cancer progression
Muralidharan-Chari, V., Clancy, J. W., Sedgwick, A., & D'Souza-Schorey, C. (2010) · Journal of Cell Science · doi:10.1242/jcs.064386 · Cited by 950
Mesenchymal stem cells: a new trend for cell therapy
Wei, X., Yang, X., Han, Z.-P., Qu, F.-F., Shao, L., & Shi, Y.-F. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.50 · Cited by 942
Kucharzewska, P., Christianson, H. C., Welch, J. E., Svensson, K. J., Fredlund, E., Ringnér, M., Mörgelin, M., Bourseau-Guilmain, E., Bengzon, J., & Belting, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220998110 · Cited by 939
Zhou, S.-L., Zhou, Z.-J., Hu, Z.-Q., Huang, X.-W., Wang, Z., Chen, E.-B., Fan, J., Cao, Y., Dai, Z., & Zhou, J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.040 · Cited by 852
Modelling Myc inhibition as a cancer therapy
Soucek, L., Whitfield, J., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., & Evan, G. I. (2008) · Nature · doi:10.1038/nature07260 · Cited by 817
Concise Review: Role of Mesenchymal Stem Cells in Wound Repair
Maxson, S., Lopez, E. A., Yoo, D., Danilkovitch-Miagkova, A., & LeRoux, M. A. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0018 · Cited by 809
Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807
Sun, Y., Campisi, J., Higano, C., Beer, T. M., Porter, P., Coleman, I., True, L., & Nelson, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2890 · Cited by 793 · cited 15×
“Transforming growth factor-β (TGF-β) and tumor necrosis factor-α (TNF-α) are commonly suggested as EMT inducers secreted from TAMs [12].”
BackgroundInfluentialRole of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Pepper, M. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.093685 · Cited by 777
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774
Au Yeung, C. L., Co, N.-N., Tsuruga, T., Yeung, T.-L., Kwan, S.-Y., Leung, C. S., Li, Y., Lu, E. S., Kwan, K., Wong, K.-K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11150 · Cited by 774
Immunobiology of mesenchymal stem cells
Ma, S., Xie, N., Li, W., Yuan, B., Shi, Y., & Wang, Y. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.158 · Cited by 771
Tolerance, DCs and tryptophan: much ado about IDO
Grohmann, U. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00072-3 · Cited by 766
Mesenchymal Stem Cells as Therapeutics
Parekkadan, B., & Milwid, J. M. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105309 · Cited by 759
Exosome mediated communication within the tumor microenvironment
Milane, L., Singh, A., Mattheolabakis, G., Suresh, M., & Amiji, M. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.029 · Cited by 742
Gocheva, V., Wang, H.-W., Gadea, B. B., Shree, T., Hunter, K. E., Garfall, A. L., Berman, T., & Joyce, J. A. (2010) · Genes & Development · doi:10.1101/gad.1874010 · Cited by 740
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733 · cited 1×
“Tumor microenvironment has been considered to be of great importance in various therapeutic attempts including one investigating the use of nanomedicine [124, 125].”
BackgroundSchrader, J., Gordon-Walker, T. T., Aucott, R. L., van Deemter, M., Quaas, A., Walsh, S., Benten, D., Forbes, S. J., Wells, R. G., & Iredale, J. P. (2011) · Hepatology · doi:10.1002/hep.24108 · Cited by 720
The elusive nature and function of mesenchymal stem cells
Nombela-Arrieta, C., Ritz, J., & Silberstein, L. E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3049 · Cited by 670
FGF Receptors: Cancer Biology and Therapeutics: CANCER BIOLOGY AND THERAPEUTICS ON FGF RECEPTORS
Katoh, M., & Nakagama, H. (2014) · Medicinal Research Reviews · doi:10.1002/med.21288 · Cited by 610
Tumor associated macrophages and neutrophils in cancer
Galdiero, M. R., Bonavita, E., Barajon, I., Garlanda, C., Mantovani, A., & Jaillon, S. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.003 · Cited by 597
Ostrand-Rosenberg, S., Sinha, P., Beury, D. W., & Clements, V. K. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.011 · Cited by 583
Therapeutic targeting of the tumor microenvironment
Joyce, J. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.024 · Cited by 582
Integrins: roles in cancer development and as treatment targets
Jin, H., & Varner, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601576 · Cited by 574
Clinical significance of macrophage heterogeneity in human malignant tumors
Komohara, Y., Jinushi, M., & Takeya, M. (2014) · Cancer Science · doi:10.1111/cas.12314 · Cited by 551
Inda, M.-D.-M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D. W. Y., Vandenberg, S., Brennan, C., Johns, T. G., Bachoo, R., Hadwiger, P., et al. (2010) · Genes & Development · doi:10.1101/gad.1890510 · Cited by 543
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., & Joyce, J. A. (2011) · Genes & Development · doi:10.1101/gad.180331.111 · Cited by 541
Ozao-Choy, J., Ma, G., Kao, J., Wang, G. X., Meseck, M., Sung, M., Schwartz, M., Divino, C. M., Pan, P.-Y., & Chen, S.-H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4709 · Cited by 538
The tumor microenvironment and its contribution to tumor evolution toward metastasis
Lorusso, G., & Rüegg, C. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0530-8 · Cited by 531
Metastatic Colorectal Cancer: Current State and Future Directions
Fakih, M. G. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7633 · Cited by 527
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Clinical applications of mesenchymal stem cells
Wang, S., Qu, X., & Zhao, R. C. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-19 · Cited by 483
Broad targeting of angiogenesis for cancer prevention and therapy
Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.01.001 · Cited by 464
The tumor microenvironment is a dominant force in multidrug resistance
Correia, A. L., & Bissell, M. J. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.006 · Cited by 443
Queen, M. M., Ryan, R. E., Holzer, R. G., Keller-Peck, C. R., & Jorcyk, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1734 · Cited by 413
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
Beckermann, B. M., Kallifatidis, G., Groth, A., Frommhold, D., Apel, A., Mattern, J., Salnikov, A. V., Moldenhauer, G., Wagner, W., Diehlmann, A., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604508 · Cited by 406
Bianco, P. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013132 · Cited by 402
Clinical implications of FLT3 mutations in pediatric AML
Meshinchi, S., Alonzo, T. A., Stirewalt, D. L., Zwaan, M., Zimmerman, M., Reinhardt, D., Kaspers, G. J. L., Heerema, N. A., Gerbing, R., Lange, B. J., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009233 · Cited by 395
TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.
Geissmann, F., Revy, P., Régnault, A., Lepelletier, Y., Dy, M., Brousse, N., Amigorena, S., Hermine, O., & Durandy, A. (1999) · PubMed · Cited by 373
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Butel, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.405 · Cited by 371
A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer
Calbo, J., van Montfort, E., Proost, N., van Drunen, E., Beverloo, H. B., Meuwissen, R., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.021 · Cited by 369
Ren, G., Zhao, X., Wang, Y., Zhang, X., Chen, X., Xu, C., Yuan, Z.-R., Roberts, A. I., Zhang, L., Zheng, B., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.08.013 · Cited by 361
Priceman, S. J., Sung, J. L., Shaposhnik, Z., Burton, J. B., Torres-Collado, A. X., Moughon, D. L., Johnson, M., Lusis, A. J., Cohen, D. A., Iruela-Arispe, M. L., et al. (2010) · Blood · doi:10.1182/blood-2009-08-237412 · Cited by 356
Shamamian, P., Schwartz, J. D., Pocock, B. J. Z., Monea, S., Whiting, D., Marcus, S. G., & Mignatti, P. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10014 · Cited by 353
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
Bergfeld, S. A., & DeClerck, Y. A. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9222-7 · Cited by 345
Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression
Shojaei, F., Singh, M., Thompson, J. D., & Ferrara, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712185105 · Cited by 334
TGF-β1 Prevents the Noncognate Maturation of Human Dendritic Langerhans Cells
Geissmann, F., Revy, P., Regnault, A., Lepelletier, Y., Dy, M., Brousse, N., Amigorena, S., Hermine, O., & Durandy, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4567 · Cited by 333
Focal adhesion signaling and therapy resistance in cancer
Eke, I., & Cordes, N. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.009 · Cited by 330
Roodhart, J. M. L., Daenen, L. G. M., Stigter, E. C. A., Prins, H.-J., Gerrits, J., Houthuijzen, J. M., Gerritsen, M. G., Schipper, H. S., Backer, M. J. G., van Amersfoort, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.010 · Cited by 305
Klopp, A. H., Spaeth, E. L., Dembinski, J. L., Woodward, W. A., Munshi, A., Meyn, R. E., Cox, J. D., Andreeff, M., & Marini, F. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1406 · Cited by 304
Martin, F. T., Dwyer, R. M., Kelly, J., Khan, S., Murphy, J. M., Curran, C., Miller, N., Hennessy, E., Dockery, P., Barry, F. P., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0734-1 · Cited by 290
The roles of mesenchymal stem cells in tumor inflammatory microenvironment
Sun, Z., Wang, S., & Zhao, R. C. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-14 · Cited by 249
Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy
Kim, B., Hong, Y., Lee, S., Liu, P., Lim, J., Lee, Y., Lee, T., Chang, K., & Hong, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125991 · Cited by 234
Self-citationExosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer
Ji, R., Zhang, B., Zhang, X., Xue, J., Yuan, X., Yan, Y., Wang, M., Zhu, W., Qian, H., & Xu, W. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1005530 · Cited by 233
Adoptive T Cell Immunotherapy For Cancer
Perica, K., Varela, J. C., Oelke, M., & Schneck, J. (2015) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10179 · Cited by 224
Cojoc, M., Peitzsch, C., Kurth, I., Trautmann, F., Kunz-Schughart, L. A., Telegeev, G. D., Stakhovsky, E. A., Walker, J. R., Simin, K., Lyle, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1924 · Cited by 223
Hiley, C., de Bruin, E. C., McGranahan, N., & Swanton, C. (2014) · Genome Biology · doi:10.1186/s13059-014-0453-8 · Cited by 223
Chau, W. K., Ip, C. K., Mak, A. S. C., Lai, H.-C., & Wong, A. S. T. (2013) · Oncogene · doi:10.1038/onc.2012.290 · Cited by 220
Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression
Wendt, M. K., Tian, M., & Schiemann, W. P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1199-1 · Cited by 210
Exosomes in development, metastasis and drug resistance of breast cancer
Yu, D., Wu, Y., Shen, H., Lv, M., Chen, W., Zhang, X., Zhong, S., Tang, J., & Zhao, J. (2015) · Cancer Science · doi:10.1111/cas.12715 · Cited by 204
Acquired and intrinsic resistance in cancer immunotherapy
Kelderman, S., Schumacher, T. N. M., & Haanen, J. B. A. G. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.011 · Cited by 197
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
Nagaraj, A. B., Joseph, P., Kovalenko, O., Singh, S., Armstrong, A., Redline, R., Resnick, K., Zanotti, K., Waggoner, S., & DiFeo, A. (2015) · Oncotarget · doi:10.18632/oncotarget.4690 · Cited by 195
Memory T cell homeostasis and senescence during aging
Akbar, A. N., & Fletcher, J. M. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.07.019 · Cited by 194
Beury, D. W., Parker, K. H., Nyandjo, M., Sinha, P., Carter, K. A., & Ostrand-Rosenberg, S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0414-210r · Cited by 183
Chen, X., Lin, X., Zhao, J., Shi, W., Zhang, H., Wang, Y., Kan, B., Du, L., Wang, B., Wei, Y., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.3 · Cited by 173
Hu, F., a Dzaye, O. D., Hahn, A., Yu, Y., Scavetta, R. J., Dittmar, G., Kaczmarek, A. K., Dunning, K. R., Ricciardelli, C., Rinnenthal, J. L., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou324 · Cited by 173
Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities
Morrissey, K., Yuraszeck, T., Li, C., Zhang, Y., & Kasichayanula, S. (2016) · Clinical and Translational Science · doi:10.1111/cts.12391 · Cited by 171
Mesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168 · cited 1×
“Because MSCs have the potential to exacerbate or reduce cancer risk, more elaborate conditions to use them in cancer therapies needs to be developed [100, 101].”
BackgroundThe αvβ6 Integrin Is Transferred Intercellularly via Exosomes
Fedele, C., Singh, A., Zerlanko, B. J., Iozzo, R. V., & Languino, L. R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.c114.617662 · Cited by 167
Joyce, J. A., Freeman, C., Meyer-Morse, N., Parish, C. R., & Hanahan, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208602 · Cited by 163
Current strategies to target p53 in cancer
Chen, F., Wang, W., & El-Deiry, W. S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.031 · Cited by 158
Santoni, M., Massari, F., Amantini, C., Nabissi, M., Maines, F., Burattini, L., Berardi, R., Santoni, G., Montironi, R., Tortora, G., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1487-6 · Cited by 156
Luo, J., Lee, S., Liang, L., Huang, C.-K., Li, L., Wen, S., & Chang, C. (2013) · Oncogene · doi:10.1038/onc.2013.233 · Cited by 155
Self-citationAkiyama, K., Ohga, N., Hida, Y., Kawamoto, T., Sadamoto, Y., Ishikawa, S., Maishi, N., Akino, T., Kondoh, M., Matsuda, A., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.029 · Cited by 154
Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond
Mittal, K., Ebos, J. M. L., & Rini, B. I. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.007 · Cited by 153
Fibroblast-mediated drug resistance in cancer
Paraiso, K. H. T., & Smalley, K. S. M. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.018 · Cited by 148
Huang, M., Liu, T., Ma, P., Mitteer, R. A., Zhang, Z., Kim, H. J., Yeo, E., Zhang, D., Cai, P., Li, C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84876 · Cited by 128
Aprelikova, O. N., Palla, J. B., Hibler, B. P., Yu, X., Greer, Y. E., Yi, M., Stephens, R., Maxwell, G. L., Jazaeri, A. A., Risinger, J. I., et al. (2012) · Oncogene · doi:10.1038/onc.2012.351 · Cited by 122
Microparticle‐associated nucleic acids mediate trait dominance in cancer
Jaiswal, R., Gong, J., Sambasivam, S., Combes, V., Mathys, J., Davey, R., Grau, G. E., & Bebawy, M. (2011) · The FASEB Journal · doi:10.1096/fj.11-186817 · Cited by 117
Zhang, H., Zhang, X., Wu, X., Li, W., Su, P., Cheng, H., Xiang, L., Gao, P., & Zhou, G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.039 · Cited by 116
Jinushi, M., & Komohara, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.01.002 · Cited by 115
Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence
Rhodes, L. V., Muir, S. E., Elliott, S. G., Guillot, L. M., Antoon, J. W., Penfornis, P., Tilghman, S. L., Salvo, V. A., Fonseca, J. P., Lacey, M. R., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0458-2 · Cited by 110
Jaiswal, R., Luk, F., Gong, J., Mathys, J., Grau, G. E., & Bebawy, M. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-37 · Cited by 106
Yamazaki, T., Pitt, J. M., Vétizou, M., Marabelle, A., Flores, C., Rekdal, Ø., Kroemer, G., & Zitvogel, L. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.35 · Cited by 106
Corso, S., & Giordano, S. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0040 · Cited by 98
Zhang, J., Zhang, H.-D., Yao, Y., Zhong, S., Zhao, J. H., & Tang, J. H. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430191 · Cited by 94
Nishimura, K., Semba, S., Aoyagi, K., Sasaki, H., & Yokozaki, H. (2012) · Pathobiology · doi:10.1159/000337296 · Cited by 89
Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
Cammarota, F., & Laukkanen, M. O. (2015) · Stem Cells International · doi:10.1155/2016/4824573 · Cited by 85
Bielecka, Z. F., Czarnecka, A. M., Solarek, W., Kornakiewicz, A., & Szczylik, C. A. (2014) · Current Signal Transduction Therapy · doi:10.2174/1574362409666140206223014 · Cited by 81
The emerging roles of exosomes in tumor–stroma interaction
Fu, H., Yang, H., Zhang, X., & Xu, W. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2145-0 · Cited by 81
Ramachandran, I. R., Condamine, T., Lin, C., Herlihy, S. E., Garfall, A. L., Vogl, D. T., Gabrilovich, D. I., & Nefedova, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.040 · Cited by 80
Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway.
Liao, H., Wang, Z., Deng, Z., Ren, H., & Li, X. (2015) · Europe PMC (PubMed Central) · Cited by 79
Targeting EGFR in non-small-cell lung cancer: Lessons, experiences, strategies
Stella, G. M., Luisetti, M., Inghilleri, S., Cemmi, F., Scabini, R., Zorzetto, M., & Pozzi, E. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.10.015 · Cited by 76
Recruitment of Circulating Breast Cancer Cells Is Stimulated by Radiotherapy
Vilalta, M., Rafat, M., Giaccia, A. J., & Graves, E. E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.011 · Cited by 76
Cancer-Associated Myeloid Regulatory Cells
Vlaeminck, Y. D., González-Rascón, A. A., Goyvaerts, C., & Breckpot, K. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00113 · Cited by 74
Bai, C., Yang, M., Fan, Z., Li, S., Gao, T., & Fang, Z. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0175-0 · Cited by 70
Kodama, M., Kitadai, Y., Tanaka, M., Kuwai, T., Tanaka, S., Oue, N., Yasui, W., & Chayama, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0818 · Cited by 68
Chang, H. W., Roh, J., Jeong, E., Lee, S., Kim, S., Choi, S., Park, S., & Kim, S. Y. (2007) · International Journal of Cancer · doi:10.1002/ijc.23069 · Cited by 64
Self-citationAder, I., Muller, C., Bonnet, J., Favre, G., Moyal, E. C., Salles, B., & Toulas, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205838 · Cited by 64
Warrier, S. R., Balu, S. K., Kumar, A. P., Millward, M., & Dharmarajan, A. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504013x13786659070154 · Cited by 63
Cancer gene therapy using mesenchymal stem cells
Uchibori, R., Tsukahara, T., Ohmine, K., & Ozawa, K. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1537-7 · Cited by 62
Kang, J., Kim, W., Kwon, T., Youn, H., Kim, J., & Youn, B. (2016) · Oncotarget · doi:10.18632/oncotarget.8208 · Cited by 60
Self-citationInhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells
Hou, L., Wang, X., Zhou, Y., Ma, H., Wang, Z., He, J., Hu, H., Guan, W., & Ma, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-1165-5 · Cited by 59
Proteome analysis of multidrug‐resistant, breast cancer–derived microparticles
Pokharel, D., Padula, M. P., Lu, J. F., Tacchi, J. L., Luk, F., Djordjevic, S. P., & Bebawy, M. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24384 · Cited by 55
Serratì, S., Chillà, A., Laurenzana, A., Margheri, F., Giannoni, E., Magnelli, L., Chiarugi, P., Dotor, J., Feijoó, E., Bazzichi, L. M., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37705 · Cited by 54
Two sides of the same coin: stem cells in cancer and regenerative medicine
Ilmer, M., Vykoukal, J. V., Boiles, A. R., Coleman, M., & Alt, E. (2014) · The FASEB Journal · doi:10.1096/fj.13-244640 · Cited by 48
Soekmadji, C., & Nelson, C. C. (2015) · BioMed Research International · doi:10.1155/2015/454837 · Cited by 46
The role of microvesicles in cancer progression and drug resistance
Jorfi, S., & Inal, J. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120273 · Cited by 46
Lykken, J. M., Horikawa, M., Minard‐Colin, V., Kamata, M., Miyagaki, T., Poe, J. C., & Tedder, T. F. (2016) · Blood · doi:10.1182/blood-2015-11-681130 · Cited by 43
Human cancer regression antigens
Kvistborg, P., van Buuren, M. M., & Schumacher, T. N. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.03.005 · Cited by 37
Han, Z., Jing, Y., Xia, Y., Zhang, S., Hou, J., Meng, Y., Yu, F., Liu, X., Wu, M., Zhang, P., et al. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-22 · Cited by 35
Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy
Johnson, L., Price, D. K., & Figg, W. D. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.22636 · Cited by 29
Human Mesenchymal Stem Cells Promote Cancer Motility and Cytokine Secretion in vitro
Scherzed, A., Hackenberg, S., Radeloff, A., Froelich, K., Rak, K., Hagen, R., & Kleinsasser, N. H. (2013) · Cells Tissues Organs · doi:10.1159/000356731 · Cited by 19
Cited by
Katoh, M. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4129 · Cited by 465
The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy
Long, L., Zhang, X., Chen, F., Pan, Q., Phiphatwatchara, P., Zeng, Y., & Chen, H. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.180 · Cited by 386
Tumor-Associated Neutrophils in Cancer: Going Pro
Wu, L., Saxena, S., Awaji, M., & Singh, R. K. (2019) · Cancers · doi:10.3390/cancers11040564 · Cited by 337
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
Wensink, G. E., Elias, S. G., Mullenders, J., Koopman, M., Boj, S. F., Kranenburg, O. W., & Roodhart, J. M. L. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00168-1 · Cited by 323
The mechanism of Warburg effect-induced chemoresistance in cancer
Liu, C., Jin, Y., & Fan, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698023 · Cited by 177
Metadata
- Authors
- Son, B., Lee, S., Youn, H., Kim, E., Kim, W., & Youn, B.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-12-11
- Volume
- 8
- Issue
- 3
- Pages
- 3933-3945
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2563791715
- Cited by
- 300
- References
- 130
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.